Atherosclerosis
Volume 200, Issue 2 , Page 447 , October 2008

To statin or to non-statin in coronary disease-considering absolute risk is the answer

Received 18 March 2008

References 

  1. Rembold CM. To statin or to non-statin in coronary disease—considering absolute risk is the answer. Atherosclerosis. 2007;295:1–6
  2. Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease. JAMA. 1975;231:360–381
  3. Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med. 1999;341:410–418
  4. Buchwald H POSCH group. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. N Engl J Med. 1990;323:946–955
  5. Valagussa F, Franzosi MG, Geraci E, et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447–455

PII: S0021-9150(08)00246-3

doi: 10.1016/j.atherosclerosis.2008.04.007

Atherosclerosis
Volume 200, Issue 2 , Page 447 , October 2008

Article Tools

* Image Usage & Resolution